Buprenorphine Chemical Structure (Buprenorphine And Naloxone Sublingual Tablets 1)
Buprenorphine And Naloxone Tablet
Product Images NDC 62175-458
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 62175-458). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Naloxone Chemical Structure (Buprenorphine And Naloxone Sublingual Tablets 2)
Tablet Placement (Buprenorphine And Naloxone Sublingual Tablets 3)
2mgbottlelabel (Buprenorphine And Naloxone Sublingual Tablets 4)
This is a medication package insert for Buprenorphine and Naloxone Sublingual Tablets, indicating the recommended storage temperature range and precautions for children who may accidentally ingest the medication. It also provides information for accessing the medication guide online. Distributed by Lannett Company, Inc., with a product code of N 2175 45232.*
8mgbottlelabel (Buprenorphine And Naloxone Sublingual Tablets 5)
This text contains information related to the distribution of sublingual tablets called Buprenorphine and Noloxone, with a strength of 8 mg/2my. It also highlights that the product should be kept out of reach for emergency medical use. It further contains details of the distributor, Lowelt Company, Inc in Philadelphia. The text also includes a code - 62175-458-32, which may be related to the product or its distribution. Overall, this seems to be a label or packaging information related to a medication.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
